ALPN-202 for Lymphoma (NEON-1 Trial)

"This clinical trial seeks 62 individuals between the ages of 18 and 75 who have lymphoma. Participants must also meet further conditions, including but not limited to: having an adult age at screening from 18-75 years old; a histologically ascertained inoperable solid tumor that is either resistant or refractory to standard treatments such as checkpoint inhibitors if applicable; metastatic cutaneous melanoma; PD-L1 positive cancers aside from cutaneous melanoma or renal cell carcinomatous cells; and measurable disease according to protocol requirements."

"This trial seeks participants who are of legal age and no older than 75 years old."

"14 different clinical sites are participating in this trial, with locations ranging from Scottsdale to Lafayette. It is advised that one selects the nearest option available to minimize their travel obligations if they choose to participate."

"We have assigned ALPN-202 a score of 1 on our safety scale due to the fact that this is only a Phase 1 trial, meaning there are limited clinical studies assessing its efficacy and safety."

"Clinicaltrials.gov demonstrates that this trial, initially posted on June 2nd 2020, is no longer looking for participants. However, there are currently 4061 other clinical studies actively recruiting patients."